Centrus Energy Corp. — 2014 Form 10-K
Business and reporting period. Centrus supplies low-enriched uranium (LEU) to nuclear utilities and is seeking to commercialize its American Centrifuge technology. This annual report covers the year ended December 31, 2014. Centrus emerged from Chapter 11 on September 30, 2014, changed its name from USEC Inc., and adopted fresh-start accounting. Consequently, reported successor results for the fourth quarter and predecessor results through September 30 are not directly comparable; full-year 2014 combined figures below are management’s non-GAAP presentation.
Financial performance and position
| Metric | 2014 combined | 2013 |
|---|---|---|
| Revenue | $514.1 million | $1,307.5 million |
| Gross profit (loss) | $(41.3) million | $(94.9) million |
| Gross margin | (8.0)% | (7.3)% |
| Operating income (loss) | $(112.8) million | $(230.7) million |
| Net income (loss) | $297.8 million | $(158.9) million |
| Cash from (used in) operations | $(110.1) million | $81.2 million |
The 2014 combined net income includes a $425.4 million net reorganization gain; it does not indicate profitable ongoing operations. Fourth-quarter successor results were revenue of $123.6 million, gross loss of $18.5 million, operating loss of $38.5 million, and net loss of $42.3 million.
- Revenue and margins: Combined revenue fell 61%, primarily as SWU deliveries declined 65% after Paducah enrichment ceased and Megatons to Megawatts purchases ended. Gross loss narrowed, mainly because of lower Paducah transition costs; gross margin nevertheless worsened to (8.0)%.
- Cash and liquidity: Year-end cash was $218.8 million, down from $314.2 million. Working capital was $366.0 million, versus a $162.7 million deficit at year-end 2013, partly reflecting cancellation of predecessor debt and preferred stock. Management expected adequate liquidity for at least 12 months. The company had no credit facility; its prior $110 million facility matured in 2013.
- Debt and obligations: New debt was $240.4 million of 8% PIK-toggle notes, generally due in 2019, potentially extendable to 2024 if specified conditions are met. The notes’ estimated year-end fair value was $121.2 million. Balance-sheet liabilities included $179.3 million in pension obligations and $211.4 million in postretirement health and life obligations. The company expects a $9.7 million 2015 contribution to non-qualified pension plans; it expected no required 2015 contribution to qualified plans.
- Inventory and backlog: Inventory was $462.2 million versus $967.6 million a year earlier. Sales backlog was $2.7 billion, down from $3.3 billion. Approximately 40% remained exposed to ACP-related contract milestones; certain customers indicated they might exercise termination rights.
Material changes, outlook, and risks
- Paducah enrichment stopped in May 2013, and leased facilities were returned to DOE in October 2014. Centrus now relies on existing inventory, Russian LEU purchases, and other suppliers. Deliveries were approximately 3 million SWU in 2014; management expected approximately 2 million in 2015.
- Management’s 2015 outlook was SWU and uranium revenue of $350–$375 million, total revenue of $425–$450 million, and year-end cash of $175–$200 million. These estimates depend on delivery timing, customer orders, DOE payments, continuation of government-funded work, and transition costs.
- The ACTDO agreement with UT-Battelle was extended through September 30, 2015, with a total price of approximately $117 million. The Administration’s FY2016 budget request included $100 million for domestic enrichment, but future appropriations and program support remained uncertain. Commercial ACP deployment was not considered economic under then-current market conditions and would require substantial additional capital; prior estimates indicated at least $4 billion.
- LEU markets remained oversupplied, with SWU prices at decade-plus lows. The Russian Supply Agreement runs through 2022, but purchase commitments exceed current backlog, prices paid could exceed market prices, and import quotas, customer acceptance, and geopolitical developments could constrain sales and deliveries.
- Significant contingencies include PBGC discussions over potential ERISA liabilities, although the company believed 2014 pension funding exceeded 90% under the new statutory method; DOE contract claims, including a $42.8 million pension-cost claim that was denied and fully reserved; and an Entergy arbitration seeking approximately $165 million in damages over alleged repudiation of two contracts. Outcomes are uncertain.
- Fresh-start fair-value adjustments created backlog and customer-relationship intangible assets and increased inventory values; amortization began in Q4 2014. The company also began immediately recognizing pension actuarial gains and losses in earnings, potentially increasing reported volatility.
Key facts investors should verify
- Separate recurring operating performance from the large, non-recurring reorganization gain and from the non-GAAP combined 2014 presentation.
- Track cash burn, customer delivery timing, and whether year-end 2015 cash guidance is achieved.
- Assess the backlog’s realizability, especially termination exposure and contract changes needed for alternative supply sources.
- Confirm continuation and funding of the ACTDO program after September 2015, and whether a credible, financed path to ACP deployment emerges.
- Monitor TENEX purchase obligations, import quotas, pricing versus market levels, and any sanctions or delivery disruption.
- Follow resolution of the DOE claims, Entergy arbitration, and PBGC pension matters, including any effect on liquidity or the New Notes guarantee.